Stryker UK ABG I Acetabular Cup Wear Cited In MHRA Medical Device Alert
This article was originally published in The Gray Sheet
Executive Summary
Clinical centers reporting problems with Stryker UK's ABG I uncemented acetabular cups had lower implant survival rates than centers not reporting problems, according to a clinical audit by UK's Medicines & Healthcare Products Regulatory Agency (MHRA)
You may also be interested in...
European Industry Decries Broad MDD Regrouping Sought By UK, France
Upclassification of artificial joint products under the Medical Devices Directive (MDD) could result in an EU market shortage of devices used in hip replacement surgery, according to European manufacturers
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.